Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28290475

CC(C)(C)OC=O.COCCCCN1CCNCC1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CXCR4 P61073 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HRH2 P25021 2/20 0.35
HRH1 P35367 2/20 0.35
SIGMAR1 Q99720 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
LMNA P02545 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL28289076 0.96 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
Tert-Butyl Formate SCHEMBL28290457 0.90 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
Tert-Butyl Formate SCHEMBL28278636 0.85 GNAO1 (0.46) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
Tert-Butyl Formate SCHEMBL27844340 0.84 HRH2 (0.42) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL10927121 0.83 CXCR4 (0.52) MEN1KMT2AALDH1A1SMN1; SMN2CXCR4
Tert-Butyl Formate SCHEMBL27601010 0.82 ALDH1A1 (0.41) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
Tert-Butyl Formate SCHEMBL27722002 0.82 TDP1 (0.39) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
Tert-Butyl Formate SCHEMBL27904056 0.82 ALDH1A1 (0.41) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL8321073 0.81 CXCR4 (0.55) MEN1KMT2AALDH1A1SMN1; SMN2CXCR4
SCHEMBL22266289 0.81 CXCR4 (0.55) MEN1KMT2AALDH1A1SMN1; SMN2CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563092-A It can be used as the 2- phenylimidazole of the active inhibitor of mammal tyrosine kinase ROR1 simultaneously [4,5-B] pyridine -7- amine derivative 坎塞拉有限公司 2019-04-02 CN disclosed